Recent Finacing
Recent Raise
Nutcracker Therapeutics develops and manufactures mRNA therapeutics using ACORN, a computer-controlled microfluidic biochip platform that automates nucleic-acid-to-nanoparticle production across discovery, clinical, and commercial scales.